Aspen Neuroscience Statistics
NASDAQ: ASPEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
12.42+0.03 (+0.24%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Aspen Neuroscience by the numbers
Aspen Neuroscience has a market capitalization of $361.2 million based on 29.08M shares outstanding. With trailing EPS of $-4.89, Aspen Neuroscience is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 2.3% below its 50-day average and 2.3% below its 200-day average.
Average daily trading volume is 352.42K shares, or about $4.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ASPE valuation vs. peer median
| Metric | ASPE | Peer median | Difference |
|---|---|---|---|
| Market cap | $361.16M | $360.39M | +0% |
| Avg. volume | 352.42K | 1.63M | -78% |
Peer median across 8 companies: PEPG, PBYI, PHAT, CTNM, IRD, MPLT, AVTX, INO.
Valuation
- Market cap
- $361.16M
- EPS (TTM)
- $-4.89
- Shares outstanding
- 29.08M
Price and trading
- Previous close
- 12.39
- Open
- 12.24
- Day range
- 12.17 – 13.19
- 52-week range
- 11.20 – 14.90
- Beta
- —
- Volume
- 130.04K
- Average volume
- 352.42K
Dividends and events
- Annual dividend
- None
Additional statistics
- Market Cap
- 361.16M
- Eps
- -4.89
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.90
- Week52 Low
- 11.20
- Avg Volume
- 352.42K
- Shares Outstanding
- 29.08M
- Ma50
- 12.72
- Ma200
- 12.72
- Pct From52w High
- -16.64%
- Pct From52w Low
- 10.89%